| Literature DB >> 29940764 |
R Meng1,2,3, J Fang1,2,3,4, Y Yu1,2,3, L K Hou1,2,3, J R Chi1,2,3, A X Chen1,2,3, Y Zhao1,2,3, X C Cao1,2,3.
Abstract
Deregulation of microRNA (miRNA) is closely related to cancer development and progression. Our previous study identified that miR-129-5p suppresses proliferation and metastasis in breast cancer cells. Herein, we determined that CBX4 is a miR-129-5p target gene. CBX4 is up-regulated in breast cancer tissues and while its over-expression promotes cell proliferation, its knockdown suppresses cell proliferation in breast cancer cells. Furthermore, CBX4 mediates miR-129-5p-induced inhibition of cell proliferation and negatively correlates with the expression of miR-129-5p expression. These combined results suggest that CBX4 is an oncogene in breast cancer cells, and that it may provide a novel therapeutic strategy for breast cancer treatment.Entities:
Keywords: CBX4; miR-129-5p; proliferation breast cancer.
Mesh:
Substances:
Year: 2018 PMID: 29940764 DOI: 10.4149/neo_2018_170814N530
Source DB: PubMed Journal: Neoplasma ISSN: 0028-2685 Impact factor: 2.575